The use of contrast-enhanced ultrasound in large vessels.
The introduction of perfluoro-based contrast agents such as SonoVue together with sensitive realtime scanning modes such as cadence contrast pulse sequences (CPS) have made possible significant advances in the management of patients with pathology affecting large vessels. This has been particularly valuable in aortic graft procedures where the lack of nephrotoxicity allows multiple repeat studies for follow-up of leaks. It has also proved valuable in situations where the flow is very slow and undetectable on conventional Doppler
Martegani
A
A
Radiology Department, Ospedale Valduce, Como, Italy. valduce@tin.it
Aiani
L
L
Borghi
C
C
D000783:Aneurysm / Q000000981:diagnostic imaging; D017541:Aneurysm, False / Q000000981:diagnostic imaging; D017542:Aneurysm, Ruptured / Q000000981:diagnostic imaging; D017544:Aortic Aneurysm, Abdominal / Q000000981:diagnostic imaging*; D001019:Aortic Rupture / Q000000981:diagnostic imaging; D001808:Blood Vessels / Q000000981:diagnostic imaging*; D003287:Contrast Media; D006406:Hematoma / Q000000981:diagnostic imaging; D006801:Humans; D045423:Microbubbles; D010743:Phospholipids; D011183:Postoperative Complications / Q000000981:diagnostic imaging; D012984:Software; D013459:Sulfur Hexafluoride; D018615:Ultrasonography, Doppler, Color
D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D013459:Sulfur Hexafluoride